Antifungal therapy for allergic bronchopulmonary aspergillosis

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 5, 2003, Pages 934-935

  Malo, Jean Luc ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Aspergillus; Asthma

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; TRIAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; BRONCHOPULMONARY ASPERGILLOMA; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG RESEARCH; EDITORIAL; HUMAN; PRIORITY JOURNAL;

EID: 0038743122     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1458     Document Type: Editorial

References (18)

1. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F, on behalf of the European Community Respiratory Health Survey. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002;325:411-8.
2. Malo J, Paquin R. Incidence of immediate sensitivity to Aspergillus fumigatus in a North American asthmatic population. Clin Allergy 1979;9:377-84.
3. Hinson K, Moon A, Plummer N. Broncho-pulmonary aspergillosis. Thorax 1952;7:317-33.
4. Pepys J. Hypersensitivity diseases of the lungs due to fungi and organic dusts. Monogr Allergy 1969;4:1-147.
5. Rosenberg M, Patterson R, Mintzer R, Cooper B, Roberts M, Harris K. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977;86:405-14.
6. Kurup V, Resnick A, Kalbfleish J, Fink J. Antibody isotype responses in Aspergillus-induced diseases. J Lab Clin Med 1990;115:298-303.
7. Igea J, Cuevas M, Marcos C, Lazaro M, Compaired J, Sanchez-Cano M. IgG subclass response to Aspergillus fumigatus. Int Arch Allergy Immunol 1993;101:277-82.
8. Leung P, Gershwin M, Coppel R, Halpern G, Novey H, Castles J. Localization, molecular weight and immunoglobulin subclass response to Aspergillus fumigatus in acute pulmonary aspergillosis. Int Arch Allergy Appl Immun 1988;85:416-21.
9. Leser C, Kauffman H, Wirchow C, Menz G. Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1992;90:589-98.
10. Slavin R, Hutcheson P, Knutsen A. Participation of cell-mediated immunity in allergic bronchopulmonary aspergillosis. Int Arch Allergy Appl Immun 1987;83:337-40.
11. Malo J, Pepys J, Simon G. Studies in chronic allergic bronchopulmonary aspergillosis. 2. Radiological findings. Thorax 1977;32:262-8.
12. Malo J, Inouye T, Hawkins R, Simon G, Turner-Warwick M, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis. 4. Comparison with a group of asthmatics. Thorax 1977;32:275-80.
13. Denning D, Wye JV, Lewiston N, Stevens D. Adjunctive therapy of allergic bronchopulmonary aspergillosis with nitraconazole. Chest 1991;100:813-9.
14. Stevens D, Schwartz H, Lee J, Moskovitz B, Jerome D, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-62.
15. Brichet FSA, Desurmont S, Grosbois J, Wallaert B, Tonnel A. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999;116:1665-8.
16. Wark P, Hensley M, Saltos N, Boyle M, Toneguzzi R, Simpson J, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003;111:952-7.
17. Varis T, Kaukonen K, Kivisto K, Neuvonen P. Plasma concentrations and effects of oral methylprenisone are considerably increased by itraconazole. Clin Pharmacol Ther 1998;64:363-8.
18. Lebrun-Vignes B, Chosidow O, Diquet B. Effects of intraconazole on the pharmokinetics on prednisolone and methylprednisolone in healthy subjects. Exp Clin Pharmacol 1996;18(Suppl):B207.